Randomized Controlled Trials as the Gold-Standard for Evaluating LLMs: A Primer for Biomedical NLP Researchers

Vicente Ivan Sanchez Carmona, Shanshan Jiang, Bin Dong


Abstract
Large Language Models (LLMs) are no longer mere laboratory objects of study. LLMs have become everyday tools in society across diverse populations and domains. In clinical contexts, LLMs have already been devised as clinical support applications. However, along with benefits, negative or adverse effects might arise, such as LLMs potentially providing psychologically distressing advice to adolescents when used for mental health support. This raises questions on the benefits of LLMs and calls for real-world evaluations: Are LLMs really helpful and effective for the intended purposes people are using them or will use them for? To answer this type of question we propose to use Randomized Controlled Trials (RCTs). RCTs are considered the most strict experimental design in the fields of Medicine, Psychiatry, Psychology, among others; however, the use of RCTs in the NLP field is almost negligible. In spite of the NLP field being the de facto locus of research on LLMs, other fields, prominently Medicine, are leading the RCT evaluations on LLMs. In this primer paper, we present a concise introduction to the principles of RCTs to guide NLP researchers to design RCT studies for evaluating LLMs.
Anthology ID:
2026.bionlp-1.31
Volume:
BioNLP 2026
Month:
July
Year:
2026
Address:
San Diego, California
Editors:
Dina Demner-Fushman, Sophia Ananiadou, Kirk Roberts, Junichi Tsujii
Venues:
BioNLP | WS
SIG:
Publisher:
Association for Computational Linguistics
Note:
Pages:
392–406
Language:
URL:
https://preview.aclanthology.org/ingest-acl-workshops/2026.bionlp-1.31/
DOI:
Bibkey:
Cite (ACL):
Vicente Ivan Sanchez Carmona, Shanshan Jiang, and Bin Dong. 2026. Randomized Controlled Trials as the Gold-Standard for Evaluating LLMs: A Primer for Biomedical NLP Researchers. In BioNLP 2026, pages 392–406, San Diego, California. Association for Computational Linguistics.
Cite (Informal):
Randomized Controlled Trials as the Gold-Standard for Evaluating LLMs: A Primer for Biomedical NLP Researchers (Sanchez Carmona et al., BioNLP 2026)
Copy Citation:
PDF:
https://preview.aclanthology.org/ingest-acl-workshops/2026.bionlp-1.31.pdf